Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;31(1):110-6.
doi: 10.1002/jmri.22008.

Early identification of aortic valve sclerosis using iron oxide enhanced MRI

Affiliations

Early identification of aortic valve sclerosis using iron oxide enhanced MRI

Amanda M Hamilton et al. J Magn Reson Imaging. 2010 Jan.

Abstract

Purpose: To test the ability of MION-47 enhanced MRI to identify tissue macrophage infiltration in a rabbit model of aortic valve sclerosis (AVS).

Materials and methods: The aortic valves of control and cholesterol-fed New Zealand White rabbits were imaged in vivo pre- and 48 h post-intravenous administration of MION-47 using a 1.5 Tesla (T) MR clinical scanner and a CINE fSPGR sequence. MION-47 aortic valve cusps were imaged ex vivo on a 3.0T whole-body MR system with a custom gradient insert coil and a three-dimensional (3D) FIESTA sequence and compared with aortic valve cusps from control and cholesterol-fed contrast-free rabbits. Histopathological analysis was performed to determine the site of iron oxide uptake.

Results: MION-47 enhanced the visibility of both control and cholesterol-fed rabbit valves in in vivo images. Ex vivo image analysis confirmed the presence of significant signal voids in contrast-administered aortic valves. Signal voids were not observed in contrast-free valve cusps. In MION-47 administered rabbits, histopathological analysis revealed iron staining not only in fibrosal macrophages of cholesterol-fed valves but also in myofibroblasts from control and cholesterol-fed valves.

Conclusion: Although iron oxide labeling of macrophage infiltration in AVS has the potential to detect the disease process early, a macrophage-specific iron compound rather than passive targeting may be required.

PubMed Disclaimer

Figures

Figure 1
Figure 1
a: Retrospectively gated cine fSPGR oblique sagittal images of control and cholesterol-fed rabbit aortic valve right coronary cusps pre- and 48 h post- intravenous administration of 11.2 mg Fe/kg MION-47. b: Average cusp thickness of control and cholesterol-fed rabbit aortic valve cusps pre- and 48 h post-MION-47 administration. Data expressed as mean ±SEM. *P < 0.05.
Figure 2
Figure 2
a: The 3D FIESTA ex vivo MR images of control and cholesterol-fed rabbit aortic valve cusps with and without MION-47. b: Average percent void area of control and cholesterol-fed rabbit aortic valve cusps with and without MION-47. Data expressed as mean ±SEM. **P < 0.01.
Figure 3
Figure 3
a–d: Immunohistochemical analysis of control and cholesterol-fed rabbit aortic valve cusps with and without MION-47. Immunohistochemistry was performed on aortic valve sections using the following antibodies: anti-RAM11 for macrophage infiltration, anti-CD31 for endothelial cells, anti-smooth muscle α-actin for myofibroblasts. Counterstaining was performed with Perl’s Prussian blue to indicate sites of iron uptake. Boxes indicate the site of magnification of lower panels. Arrowheads indicate colocalized staining. Example scale bars for each magnification can be seen in right hand panels.

References

    1. Stewart MD, Siscovick MD, Lind MS, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630–634. - PubMed
    1. O’Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more) Arterioscler Thromb Vasc Biol. 2006;26:1721–1728. - PubMed
    1. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220–1225. - PubMed
    1. Yeo K, Low R. Aortic stenosis: assessment of the patient at risk. J Magn Reson Imaging. 2007;20:509–516. - PubMed
    1. Otto C, Kuusisto J, Reichenbach D, Gown A, O’Brien KD. Characterization of the early lesion of ’degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844–853. - PubMed

Publication types

Substances